Evidence map›Paper›PMID 9351824›Full record

ArticleThe EMBO journal1997

Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3.

J Gao, K E Zoller, M H Ginsberg, J S Brugge, S J Shattil

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The EMBO journal, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 168 citations in OpenAlex.

  1. Platelet Membrane Receptors and Signalling Pathways.Handbook of experimental pharmacology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Integrin αBlood · 2017
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Platelet mechanosensing of substrate stiffness during clot formation mediates adhesion, spreading, and activation.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J GaoDepartment of Vascular Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
K E Zoller
M H Ginsberg
J S Brugge
S J Shattil
Scripps Research Institute · US

Funding

TYROSINE KINASE C-ABL AND BCR-ABL IN INTEGRIN DEPENDENT SIGNALINGP01HL057900 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHATTIL, SANFORD J · 1997 to 2012
$17.4M
Regulation of Integrin Alpha4 BetalR01AR027214 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GINSBERG, MARK HOWARD · 1986 to 2010
$3.5M
PLATELETS IN RHEUMATIC DISEASER37AR027214 · NIAMS · SCRIPPS RESEARCH INSTITUTE · PI GINSBERG, MARK HOWARD · 1991 to 2000
$279k
STUDIES ON THE C-SRC PROTO-ONCOGENE PRODUCT IN NEURONSR01CA047572 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRUGGE, JOAN SIEFERT · 1988 to 1997
–
NCI NIH HHS CA47572NHLBI NIH HHS P01 HL57900NIAMS NIH HHS AR27214
6 · The paper itself

Abstract

pp72syk is essential for development and function of several hematopoietic cells, and it becomes activated through tandem SH2 interaction with ITAM motifs in immune response receptors. Since Syk is also activated through integrins, which do not contain ITAMs, a CHO cell model system was used to study Syk activation by the platelet integrin, alpha IIb beta 3. As in platelets, Syk underwent tyrosine phosphorylation and activation during CHO cell adhesion to alpha IIb beta 3 ligands, including fibrinogen. This involved Syk autophosphorylation and the tyrosine kinase activity of Src, and it exhibited two novel features. Firstly, unlike alpha IIb beta 3-mediated activation of pp125FAK, Syk activation could be triggered by the binding of soluble fibrinogen and abolished by truncation of the alpha IIb or beta 3 cytoplasmic tail, and it was resistant to inhibition by cytochalasin D. Secondly, it did not require phosphorylated ITAMs since it was unaffected by disruption of an ITAM-interaction motif in the SH2(C) domain of Syk or by simultaneous overexpression of the tandem SH2 domains. These studies demonstrate that Syk is a proximal component in alpha IIb beta 3 signaling and is regulated as a consequence of intimate functional relationships with the alpha IIb beta 3 cytoplasmic tails and with Src or a closely related kinase. Furthermore, there are fundamental differences in the activation of Syk by alpha IIb beta 3 and immune response receptors, suggesting a unique role for integrins in Syk function.

Indexed as

Amino Acid SequenceAnimalsBlood PlateletsCell AdhesionCell Adhesion MoleculesCHO CellsCricetinaeCricetulusEnzyme ActivationEnzyme PrecursorsFibrinogenFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesHumansIntracellular Signaling Peptides and ProteinsMolecular Sequence DataCell Adhesion MoleculesEnzyme PrecursorsFibrinogenFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesIntracellular Signaling Peptides and ProteinsPlatelet Glycoprotein GPIIb-IIIa ComplexProtein-Tyrosine KinasesPTK2 protein, humanReceptors, ImmunologicRecombinant Fusion ProteinsSyk KinaseSYK protein, human

Identifiers

PMID9351824
PMCPMC1170248
OpenAlexW2064540749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.